IDI COGT 深 沪
等待开盘 10-11 09:30:00 美东时间
16.27
+0.080
+0.49%
华盛通- 最 高16.42
- 今 开16.27
- 成交量 188.61万股
- 最 低 15.83
- 昨 收 16.19
- 总市值 22.78亿
- 52周最高 16.46
- 市盈率 静 --
- 换手率 1.35%
- 52周最低 3.72
- 委 比 -44.03%
- 总股本 1.40亿
- 历史最高 27.80
- 量 比 0.85
- 振 幅 3.64%
- 历史最低 3.67
- 每 手 1
- 风险率 2.84%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Theriva Biologics To Present VCN-12 And VCN-01 Preclinical Data At ESGCT, Highlighting Novel Antitumor Mechanism And Intracranial Feasibility For Brain Tumors
- Preclinical data for VCN-12, the next candidate from Theriva's VCN-X discovery program, highlight a novel mechanism of action with the potential to significantly improve antitumor effects -- Pre-ESGCT meeting monograph
10-06 20:03
Cogent Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Cogent Biosciences, a biotech company focused on precision therapies for genetically defined diseases, announced that its independent Compensation Committee granted equity awards to 10 new employees under the 2020 Inducement Plan. The awards, totaling 299,200 nonqualified stock options, were approved on September 25, 2025, with a grant date of September 29, 2025, and a four-year vesting schedule. The company also highlighted its advanced clinical...
09-29 20:05
MPS Completes Major IDITSuite Upgrade with Sapiens
Medical Protection Society has upgraded to a new version of IDITSuite for Property & Casualty, gaining future-proof architecture and extended lifecycle support ROCHELLE PARK, N.J., Sept. 17,...
09-17 19:11
Cogent Biosciences Signs Lease for New Headquarters
An update from Cogent Biosciences ( ($COGT) ) is now available. On September 5,...
09-12 05:04
美股大行评级 | 潜在涨幅403.28%！瑞杰金融首予Kalaris Therapeutics"强烈买入"评级，目标价23美元
今日重点评级关注：花旗：维持Ionis Pharmaceuticals"买入"评级，目标价从69美元升至84美元；Melius Research：上调康明斯评级至"买入"，目标价500美元
09-04 09:49
Macy's Increases FY2025 Outlook, Joins REV Group, HealthEquity, Alphabet and Wellness And Other Big Stocks Moving Higher On Wednesday
U.S. stocks were mixed, with the Dow Jones index falling over 150 points on Wed...
09-03 22:10
Guggenheim Maintains Buy on Cogent Biosciences, Raises Price Target to $20
Guggenheim analyst Charles Zhou maintains Cogent Biosciences (NASDAQ:COGT) with a Buy and raises the price target from $17 to $20.
08-25 20:21
CarParts.com Reports Second Quarter 2025 Results
TORRANCE, Calif., Aug. 12, 2025 /PRNewswire/ -- CarParts.com, Inc. (NASDAQ: PRTS), a leading eCommerce provider of automotive parts and accessories, and a premier destination for vehicle rep...
08-13 04:01
WOW! REPORTS SECOND QUARTER 2025 RESULTS
Greenfield markets now pass 91.1 thousand homes with a penetration rate at 16.0% ENGLEWOOD, Colo., Aug. 11, 2025 /PRNewswire/ -- WideOpenWest, Inc. ("WOW!" or the "Company") (NYSE: WOW), one...
08-12 04:54
AVALON HOLDINGS CORPORATION ANNOUNCES SECOND QUARTER RESULTS
WARREN, Ohio, Aug. 8, 2025 /PRNewswire/ -- Avalon Holdings Corporation (NYSE Amex: AWX) today announced financial results for the second quarter of 2025. Net operating revenues in the second...
08-09 05:05
